AL-TRZ Tirzepatide Research Peptide | Elevora Bio — ElevoraBio

Research use only

I certify that I am a qualified researcher, that I am at least 21 years of age, and that all products purchased will be used exclusively for in-vitro laboratory research. Products are not for human or animal consumption.

Leave

Research materials for laboratory use only · Batch-specific analytical documentation available where applicable

ElevoraBio Advanced Peptide Research
Cart
Metabolic Pathway Research

AL-TRZ (Tirzepatide)

See batch-specific COA purity CAS 2023788-19-2

AL-TRZ is a synthetic lipid-conjugated research peptide investigated in experimental receptor-binding and metabolic-signaling models.

$139.00
Vial size

Free shipping over $200.00
Batch-specific analytical documentation available where applicable
Temperature-controlled packaging where applicable
Encrypted checkout

Research use only. All products are sold strictly for laboratory research use only. Not for human or veterinary consumption.

CAS number
2023788-19-2
Molecular formula
C225H348N48O68
Molecular weight
4813.45 g/mol
Purity
See batch-specific COA
Physical form
White to off-white lyophilized powder
Storage
Store lyophilized at -20°C, protected from light and moisture
SKU
EB-ALTRZ
AL-TRZ is the Elevora Bio designation for Tirzepatide, a synthetic 39-amino-acid research peptide structurally derived from the native GIP sequence.

The compound incorporates non-natural amino acids, a C-terminal amide, and a lipid-associated structural modification. These characteristics are relevant to its molecular design and analytical identification.

Experimental research has examined AL-TRZ in controlled models involving receptor binding, peptide structure, molecular interactions, and metabolic-signaling pathways.

Each vial contains the selected quantity of lyophilized AL-TRZ research material. Batch-specific analytical documentation should be consulted for the identity, purity, and specifications of the applicable tested lot.

For research use only. Not for human or veterinary use, administration, or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.
AL-TRZ has been investigated in experimental studies involving GIP- and GLP-1-receptor binding, molecular pharmacology, peptide stability, and metabolic-signaling pathways.

Research involving this compound does not establish the safety, efficacy, dosing, pharmacokinetics, or suitability of an Elevora Bio research material for human or veterinary use.

The presence of Tirzepatide as an active ingredient in FDA-approved medicines does not make this research material therapeutically equivalent to those products. It does not share their approved formulation, manufacturing authorization, clinical labeling, delivery system, or regulatory status.

References to published literature are provided for scientific context only and do not constitute medical advice or a claim of efficacy.

Packaging

Vials are lyophilized, sealed, and shipped in insulated, temperature-controlled packaging where applicable.

Delivery

In-stock orders are prepared for dispatch on business days. Domestic transit is typically 2–5 business days depending on the service selected at checkout.

Storage on arrival

Store lyophilized at -20°C, protected from light and moisture. Store according to the product-specific laboratory storage specifications and applicable analytical documentation.

Researchers also ordered

SLU-PP-332 5 mg
Metabolic Pathway Research

SLU-PP-332 5 mg

CAS 303760-60-3

SLU-PP-332 is a synthetic small-molecule ERR agonist investigated in experimental receptor-signaling and cellular metabolic-pathway models.

$109.00

View